SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

National Association for Continuing Education
Nicola Alexander Hanania, MD, MS
Associate Professor
Director, Airways Clinical Research Center
Member, Vice Chair of Research Group
Department of Medicine
Baylor College of Medicine
Director, Asthma and COPD Clinic
Ben Taub Hospital
Houston, TX

Gregg Sherman, MD
Family Practice
Plantation, FL

: Individualizing Asthma Care: Addressing Type 2 Inflammation
Activity/Course #:
: NCME373
: Free
Release/Start Date:
: May 15 2019
Expiration Date:
: May 14 2020
: Primary Care Medicine
Target Audience:
: Primary Care Physicians, Nurse Practitioners, Physician Assistants
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.50 pharmacology hour(s)
Hardware/Software Requirements:
Program Summary
Asthma is a heterogenous disorder usually characterized by chronic airway inflammation, and defined by respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough that vary over time and in intensity, together with variable expiratory airflow limitation. The disorder affects 18.7 million adults and 7 million children in the United States.

This activity will examine newer concepts in the pathophysiology of asthma and type 2 inflammation, tools for clinical assessment, individualized treatment strategies for patients with moderate-to-severe asthma, and the impact of comorbid conditions to improve asthma control.

This webcast was recorded live at the Conversations in Primary Care 2019 and is being used with the permission of the presenters.
Learning Objectives
After completing this program participants should be able to:
  1. Describe the newer concepts in the pathophysiology of asthma and type 2 inflammation and the implications of targeted biologic therapies
  2. Implement tools for clinical assessment of asthma control and risk factors for poor asthma outcomes
  3. Individualize treatment of moderate-to-severe asthma
  4. Discuss the impact of comorbid conditions on asthma control and the evidence approach to their treatment
How to obtain the CME Certificate
  1. Register for the course at
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 60% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1 contact hour of continuing education which includes 0.50 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Dr. Hanania is an Advisory Board member for AstraZeneca, Sanofi and GlaxoSmithKline. He is also a researcher for Boehringer Ingelheim.

Contributing Faculty
Dr. Maselli serves as a consultant for Novartis, AstraZeneca, Sanofi Regeneron and GlaxoSmithKline, and part of the speaker bureau for Sunovion, Sanofi Regeneron, and GlaxoSmithKline.

Activity Planning Committe
Gregg Sherman, MD, Course Director, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Michelle Frisch, MPH, has no relationships to disclose.

Daniela Hiedra, BA, has no relationships to disclose.

Sandy Bihlmeyer, MEd, has no relationships to disclose.
Commercial Support
This educational activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.